PULSE BIOSCIENCES, INC. Logo

PULSE BIOSCIENCES, INC.

Developing nsPFA bioelectric tech for precise, non-thermal tissue ablation in cardiology.

PLSE | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
3957 POINT EDEN WAY, 94545 HAYWARD
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Pulse Biosciences, Inc. is a bioelectric medicine company developing a proprietary therapeutic platform based on Nanosecond Pulsed Field Ablation (nsPFA) technology. This novel, nonthermal energy modality is designed to precisely ablate cellular tissue while sparing adjacent noncellular structures. The company's primary focus is on advancing treatments in cardiology, particularly for atrial fibrillation, through its investigational CellFX® nsPFA™ 360 Cardiac Catheter and Cardiac Clamp. Pulse Biosciences is also expanding its nsPFA technology into other medical applications, including the development of a percutaneous electrode for the treatment of benign thyroid nodules. The company is actively advancing its product pipeline through clinical studies and regulatory submissions to establish nsPFA as a new standard of care in various medical procedures.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PULSE BIOSCIENCES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PULSE BIOSCIENCES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PULSE BIOSCIENCES, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
3-D Matrix,Ltd. Logo
Develops peptide-based medical devices for surgical bleeding control and wound healing.
Japan 7777
aap Implantate AG Logo
Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.
Germany AAQ1
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France ABLD
Adagio Medical Holdings, Inc. Logo
Develops ultra-low temp cryoablation catheters for cardiac arrhythmia treatment.
United States of America ADGM
Advanced Biomed Inc. Logo
Develops microfluidic biochips for rapid, affordable liquid biopsy in precision oncology.
United States of America ADVB
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for wound care and surgery.
United Kingdom AMS
AETHLON MEDICAL INC Logo
Develops a blood-filtering device to combat resistant cancers and life-threatening viruses.
United States of America AEMD
Affluent Medical Logo
Developing minimally invasive, restorative implants for structural heart disease and urology.
France AFME
Ainos, Inc. Logo
Develops AI-powered 'SmellTech' diagnostics and immune therapies for point-of-care testing.
United States of America AIMD
AIOBIO Co., Ltd. Logo
Develops AI biofluorescence dental tools for early detection of caries and plaque.
South Korea 447690

Talk to a Data Expert

Have a question? We'll get back to you promptly.